The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis

@article{Shyu1993TheAB,
  title={The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis},
  author={Wen Chyi Shyu and Kenneth A. Pittman and D. S. Robinson and Rashmi H. Barbhaiya},
  journal={European Journal of Clinical Pharmacology},
  year={1993},
  volume={45},
  pages={559-562}
}
The absolute bioavailability (f) and pharmacokinetics of transnasal butorphanol were evaluated in patients experiencing rhinitis. In an open three-way crossover study, a single 2-mg dose of butorphanol tartrate was administered by intravenous bolus injection (Treatment A), by the transnasal route (Treatment B), or by the transnasal route with pretreatment… CONTINUE READING